Approval · Notice of Compliance 12404 · 2011
TEVA-ZOLMITRIPTAN: Notice of Compliance 12404
Issued June 7, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12404
- Date
- June 7, 2011
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Migraine therapy / 5-HT1 receptor agonist
- Canadian reference product
- ZOMIG (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-ZOLMITRIPTAN | 02313952 | Cancelled Pre Market |
| TEVA-ZOLMITRIPTAN | 02313960 | Marketed |
Medicinal ingredients
- ZOLMITRIPTAN 1 MG per TAB
- ZOLMITRIPTAN 2.5 MG per TAB